Global Data: Pipieline Assessment and Market Forecasts for Influenza Vaccines
GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines – Pipeline Assessment and Market Forecasts to 2017″. The report is an essential source of information and analysis on the global Influenza Vaccines market. The report identifies the key trends shaping and driving the global Influenza Vaccines market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Influenza Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. GlobalData estimated the global influenza vaccines market to be worth .8 billion in 2009. It is forecast to grow at a CAGR of 8% to reach billion by 2017. This high growth forecast is primarily attributed to an increase in the patient population as a result of the increasing world population, and the need to get vaccinated each year. This growth will be further supported by increased production capacities of companies to cater to the rising demand. The strong product pipeline will complement the existing products by providing effective treatment options
For Sample Pages please click the link below
This report offers you:
* The scope of the report includes:
* Annualized global Influenza Vaccines market revenue data from 2001 to 2009, forecast for eight years to 2017.
* Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
* Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall in five major vaccine classes: inactivated vaccine, live attenuated vaccine, DNA vaccine, antigenic vaccine and others. Pipeline analysis covers the vaccines which are in early or late stage of development for Influenza.
* Analysis of the current and future market competition in the global Influenza Vaccines market. The key future market players covered are Novartis, CSL Limited, MedImmune, GSK and Sanofi Aventis.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the Influenza Vaccines market.
For More Information please click the link below
About Company:
GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.
Visit our Report Store
http://www.globaldata.com/reportstore/
Article from articlesbase.com
No Comments
No comments yet.
RSS feed for comments on this post. TrackBack URL
Sorry, the comment form is closed at this time.